This $1,225,171 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced research at The Leland Stanford Junior University to develop early detection methods for kidney cancer using tumor-educated platelets. The four-year project, running from August 1, 2024 to July 31, 2028, will leverage Stanford's expertise in medicine, engineering, and biomedical research to address this critical medical challenge. The Military Medical Research and Development program funds innovative scientific studies across diverse health domains to improve outcomes for military personnel and the broader public. This grant award reflects the government's strategic approach to advancing transformative medical research through collaborations with leading academic institutions like Stanford.
Generated 3/25/25, 1:46 AM